RORC and cancer: To compare the anti-growth and -survival activities in cancer cells of UA and digoxin with synthetic RORγ inhibitors, we included XY018, which was characterized in its activity in antagonizing the function of RORγ in control of gene programs in the cancer cells and tumors (Wang et al., 2016; Cai et al., 2019; Chen et al., 2022).